Facebook
X
LinkedIn
ForwardClusterbusters 21st Annual U.S. Conference - October 8 to 10, 2026
This program will include an overview of current treatments and ideas regarding cluster headache. It will feature topics specific to cluster headache and foster a deeper understanding of the patient's lived experience with the disease. The program will also include some of the latest research on cluster headache and a discussion about future research goals for the disease. The course is designed to provide a better understanding of the differences between treating cluster headache and other primary headache disorders. It will enable attendees to enhance their clinical and research skills by gaining knowledge of the latest concepts concerning diagnosis, treatment, and mechanisms of cluster headache.
Target Audience
This program is designed to be useful to practitioners interested in headache diseases, patients, and supporters. We believe that learning together as a community is mutually beneficial for all who live with cluster headache. We hope to attract headache specialists, primary care providers, general neurologists, nurse practitioners, dentists, psychologists, and other health care providers who do not focus exclusively on headache treatment but may encounter people with headache diseases. We have learned that very few providers understand the nuances of treating cluster headache. With some basic education, HCPs can be equipped to identify and manage this population. Some topics and sessions will offer a deep dive and practical demonstrations of treatments, while others will focus more broadly on cluster headache.
Learning Objectives
At the conclusion of this activity, the learner or healthcare team will be able to:
- Create office interactions with patients that address their needs.
- Explain prescribing models for current cluster headache treatment options.
- Discuss treatment options with consideration of the patient.
- Tailor treatment plans to transition the uncontrolled and overmedicated patient to stability.
- Describe advances in technology and how current and future tech can be implemented in the care of the cluster headache patient.
- Discuss recent advances in policies regarding alternative treatments for cluster headache.
- Explain how the history of cluster headache treatment has shaped current understanding in healthcare.
- Describe recent research into cluster headache treatments.
- Discuss findings and implications of recent real-world data collected on efficacy of medicines and psychedelics for cluster headache.
- Discuss the role of psychological perspectives on cluster headache and future research into headache diseases.
- Discuss the potential of DMT in the management of cluster headache.
- Describe the benefits and pitfalls of a multidisciplinary approach to cluster headache management.
- Examine how family dynamics can impact the cluster headache patient.
Course summary
- 8.75 AMA PRA Category 1 Credit™
Boston University Chobanian & Avedisian School of Medicine designates this Enduring activity for a maximum of 8.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 8.75 Participation
CCE Program Manager - Naomi Moeller
In support of improving patient care, Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians
Boston University Chobanian & Avedisian School of Medicine designates this live activity for a maximum of 8.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Available Credit
- 8.75 AMA PRA Category 1 Credit™
Boston University Chobanian & Avedisian School of Medicine designates this Enduring activity for a maximum of 8.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 8.75 Participation